Evolus clinical trials we track

Check company identity source

Phase 2 1 trial

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2019-02-01DayPrabotulinumtoxinA-XvfsEvolus, Inc. · EOLSFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761085", "applicant_as_listed_by_fda": "EVOLUS INC", "brand_names": ["JEUVEAU"], "active_ingredients": ["PRABOTULINUMTOXINA-XVFS"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20190201", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.